Article
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
The Journal of molecular diagnostics : JMD - 1 Nov 2014
MacConaill Laura E, Garcia Elizabeth, Shivdasani Priyanka, Ducar Matthew, Adusumilli Ravali, Breneiser Marc, Byrne Mark, Chung Lawrence, Conneely Jodie, Crosby Lauren, Garraway Levi A, Gong Xin, Hahn William C, Hatton Charlie, Kantoff Philip W, Kluk Michael, Kuo Frank, Jia Yonghui, Joshi Ruchi, Longtine Janina, Manning Allison, Palescandolo Emanuele, Sharaf Nematullah, Sholl Lynette, van Hummelen Paul, Wade Jacqueline, Wollinson Bruce M, Zepf Dimity, Rollins Barrett J, Lindeman Neal I
Abstract excerpt
Ongoing cancer genome characterization studies continue to elucidate the spectrum of genomic abnormalities that drive many cancers, and in the clinical arena assessment of the driver genetic alterations in patients is playing an increasingly important diagnostic and/or prognostic role for many cancer types. However, the landscape of genomic abnormalities is still unknown for less common cancers, and the influence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.